All filters
Slidesets
Immunological response after stopping Nucs- Andre Boonstra
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Virological biomarkers in patients stopping Nucs- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Review of the FDA/EMA HBV Endpoints Meeting- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are ALT Flares Associated with Improved Virological Clearance- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
High Resolution of Exhausted T cells Ex Vivo in Chronic HBV Infection- Robert Thimme
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Restoration of B cell Antibody Production in Chronic HBV patients- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Roche TLR-7 agonist- Lu Gao
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Using FNAB to Investigate Intrahepatic Immunology- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
sIRNA based therapy for Chronic Hepatitis B Treatment- Michael Biermer
Presented at:
International Workshop on HBV Cure 2019
Slidesets
HDV Trials- Robert Gish
Presented at:
International Workshop on HBV Cure 2019
Slidesets
NAP's latest update in HBV and HDV- Andrew Vaillant
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Study Design with New Combinations- Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Hypothesized Synergies in new cobmination treatment beyond nucs- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2019